Simon Plyte

Vice President Immuno-Oncology
Merus
Nina E. Weisser
Dr Plyte is responsible for creating and maintaining an innovative Immune-Oncology portfolio of Bi-specific (Biclonic) antibodies for the treatment of Cancer. He is leading the research and development of drugs at the preclinical level from exploratory idea through to IND submission.

Sessions

No data was found